U. N. KARAKULAK Et Al. , "Four-Dimensional Echocardiographic Evaluation of Left Ventricular Systolic Functions in Patients with Chronic Myeloid Leukaemia Receiving Tyrosine Kinase Inhibitors," CARDIOVASCULAR TOXICOLOGY , vol.21, no.3, pp.216-223, 2021
KARAKULAK, U. N. Et Al. 2021. Four-Dimensional Echocardiographic Evaluation of Left Ventricular Systolic Functions in Patients with Chronic Myeloid Leukaemia Receiving Tyrosine Kinase Inhibitors. CARDIOVASCULAR TOXICOLOGY , vol.21, no.3 , 216-223.
KARAKULAK, U. N., ALADAĞ KARAKULAK, E., HEKİMSOY, V., ŞAHİNER, M. L., KAYA, E. B., ÖZER, N., ... AKSU, S.(2021). Four-Dimensional Echocardiographic Evaluation of Left Ventricular Systolic Functions in Patients with Chronic Myeloid Leukaemia Receiving Tyrosine Kinase Inhibitors. CARDIOVASCULAR TOXICOLOGY , vol.21, no.3, 216-223.
KARAKULAK, UĞUR Et Al. "Four-Dimensional Echocardiographic Evaluation of Left Ventricular Systolic Functions in Patients with Chronic Myeloid Leukaemia Receiving Tyrosine Kinase Inhibitors," CARDIOVASCULAR TOXICOLOGY , vol.21, no.3, 216-223, 2021
KARAKULAK, UĞUR N. Et Al. "Four-Dimensional Echocardiographic Evaluation of Left Ventricular Systolic Functions in Patients with Chronic Myeloid Leukaemia Receiving Tyrosine Kinase Inhibitors." CARDIOVASCULAR TOXICOLOGY , vol.21, no.3, pp.216-223, 2021
KARAKULAK, U. N. Et Al. (2021) . "Four-Dimensional Echocardiographic Evaluation of Left Ventricular Systolic Functions in Patients with Chronic Myeloid Leukaemia Receiving Tyrosine Kinase Inhibitors." CARDIOVASCULAR TOXICOLOGY , vol.21, no.3, pp.216-223.
@article{article, author={UĞUR NADİR KARAKULAK Et Al. }, title={Four-Dimensional Echocardiographic Evaluation of Left Ventricular Systolic Functions in Patients with Chronic Myeloid Leukaemia Receiving Tyrosine Kinase Inhibitors}, journal={CARDIOVASCULAR TOXICOLOGY}, year=2021, pages={216-223} }